Articles related to INSOMNIA/SLEEP DISORDERS

Recent findings suggest zolpidem may significantly reduce the brain’s natural cleaning mechanisms during sleep, with potential implications for long-term neurological health.

Long-term use of dopaminergic medications shows correlation with gradual RLS symptom deterioration, prompting a shift toward alpha-2-delta ligand calcium channel blockers as preferred pharmacological interventions.

Nearly half of clinical trial participants achieved such significant improvements that their OSA symptoms were effectively resolved, marking a significant advancement in treating this complex disorder.

Greasy, high-fat foods can take up to 6 hours to digest, potentially disrupting sleep and exacerbating reflux symptoms when lying down.

Actigraphy devices revealed significant improvements in sleep patterns with nighttime levodopa use, despite patients not perceiving these changes subjectively.

CBTI offers a non-pharmacological approach to treating insomnia, focusing on behavioral changes that can lead to long-term improvements in sleep quality.